Top Markets
Coin of the day
Guangzhou Wondfo Biotech Co.,Ltd Guangzhou Wondfo Biotech Co.,Ltd

Guangzhou Wondfo Biotech Co.,Ltd

300482
Clasificación en acciones #9000
Guangzhou Wondfo Biotech Co.,Ltd operates as a biotechnology enterprise,... Guangzhou Wondfo Biotech Co.,Ltd operates as a biotechnology enterprise, specializing in the research, development, production, and distribution of point-of-care testing (POCT) products. The company additionally provides rapid diagnostic tools and comprehensive solutions for managing chronic diseases. Its product catalog features an array of rapid test kits, addressing conditions like COVID-19, substance abuse, certain cancers, infectious diseases, fertility, and sexually transmitted infections. Furthermore, Wondfo Biotech offers immunofluorescence devices designed to identify cardiovascular conditions, inflammatory markers, kidney damage, hormonal imbalances (including sex hormones and thyroid function), diabetes, and specific tumor indicators. The firm also supplies analytical instruments, such as blood gas, optical coagulation, and dry chemistry analyzers. Established in 1992, the company's main operations are based in Guangzhou, China.
Precio por acción
$2.39
Última sincronización: 2026-08-28
Capitalización bursátil
$1.12B
Cambio (1 día)
0.24%
Cambio (1 año)
-23.68%
País
CN
Comercio Guangzhou Wondfo Biotech Co.,Ltd (300482)

Categoría

Ganancias de Guangzhou Wondfo Biotech Co.,Ltd (300482)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Guangzhou Wondfo Biotech Co.,Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Guangzhou Wondfo Biotech Co.,Ltd desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US